Skip to main content
Back to Global Brain Corporation

Global Brain Corporation's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by Global Brain Corporation. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$132.3M

Therapeutics Portfolio Companies (4)

Export
BiotechnologyHealth CareNeuroscienceTherapeutics

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Boston, United States
March 2026
$3.3M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

San Carlos, United States
March 2024
$12.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Global Brain Corporation's Full Portfolio

View all companies funded by Global Brain Corporation across every industry and funding stage.

View Full Global Brain Corporation Portfolio